Alaxia

General Information

Company Name

Alaxia

Founded Year

2008

Location (Offices)

Founders / Decision Makers

Number of Employees

Industries

Biotechnology

Funding Stage

Social Media

Alaxia - Company Profile

Alaxia is a leading French biotech firm founded in 2008, dedicated to pioneering therapeutic advancements in respiratory health through its innovative antimicrobial solutions. The company specializes in creating therapeutic solutions for respiratory illnesses with a focus on cystic fibrosis using its unique peroxidase platform. Their flagship drug candidate, ALX-009, is designed to target even the most resilient bacterial strains associated with cystic fibrosis, offering a promising treatment option for this challenging condition.

Taxonomy: biotech firm, respiratory health, therapeutic advancements, cystic fibrosis, antimicrobial solution, peroxidase platform, drug candidate, innovative compound, French biotech, private company, respiratory diseases, bacterial strains, therapeutic solutions, resilient bacteria, ALX-009